Form 144 Inotiv For: 29 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inotiv Inc (NOTV)
Inotiv Inc stock price live, this page displays NASDAQ NOTV stock exchange data. View the NOTV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Inotiv Inc real time stock price chart below.
What Is the Inotiv Inc Stock Price Today?
The Inotiv Inc stock price today is 0.304.
What Is the Stock Symbol for Inotiv Inc?
The stock symbol for Inotiv Inc is "NOTV."
What Stock Exchange Does Inotiv Inc Trade On?
Inotiv Inc is listed and trades on the NASDAQ stock exchange.
Is Inotiv Inc a Good Stock to Buy?
Determining whether Inotiv Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOTV quote. (ISIN: US45783Q1004)
What Is the Inotiv Inc Stock Price Today?
The Inotiv Inc stock price today is 0.304.
What Is the Stock Symbol for Inotiv Inc?
The stock symbol for Inotiv Inc is "NOTV."
What Stock Exchange Does Inotiv Inc Trade On?
Inotiv Inc is listed and trades on the NASDAQ stock exchange.
Is Inotiv Inc a Good Stock to Buy?
Determining whether Inotiv Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOTV quote. (ISIN: US45783Q1004)
0.304
+0.010(+3.33%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.297
0.310
52 wk Range
0.216
3.320
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2970.310
52 wk Range
0.2163.320
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NOTV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
3.250
Upside
+969.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
- Bioanalytical Sys receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 144 Inotiv For: 29 April
- Investing.com
- Form 8K Inotiv Inc For: 24 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.250
(+969.08% Upside)
Inotiv Inc Earnings Call Summary for Q1/2026
- Inotiv reported Q1 2026 EPS of -0.83, missing forecasts by 62.75%, with revenue of $120.9M falling short of expected $126.53M, causing shares to drop 19.27%
- Despite total revenue increasing 0.8% YoY, the company posted a $28.4M net loss, with DSA revenue up 12% but RMS revenue down 5.4%
- The company's $405.8M total debt raises financial stability concerns, with Adjusted EBITDA at just $1.8M (1.5% of revenue)
- CEO Bob Leasure emphasized innovation strategy to avoid commoditization, while the company expects flat NHP revenue for the year with margin improvements in H2 2026
- Management is focusing on debt refinancing and cost reduction strategies, though no formal financial guidance was provided beyond expectations for H2 improvement
Last Updated: 02/09/2026, 10:52 PM
Read Full TranscriptEarnings
Latest Release
Feb 09, 2026
EPS / Forecast
-0.83 / -0.51
Revenue / Forecast
120.9M / 126.53M
Compare NOTV to Peers and Sector
Metrics to compare | NOTV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNOTVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −6.8x | −0.6x | |
PEG Ratio | 0.00 | −0.23 | 0.00 | |
Price/Book | 0.1x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 3.0x | 3.2x | |
Upside (Analyst Target) | - | 66.0% | 48.1% | |
Fair Value Upside | Unlock | 8.2% | 5.8% | Unlock |
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Inotiv (NOTV) Stock Price Today?
The Inotiv stock price today is 0.304 USD.
What Stock Exchange Does Inotiv Trade On?
Inotiv is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Inotiv?
The stock symbol for Inotiv is "NOTV."
What Is the Inotiv Market Cap?
As of today, Inotiv market cap is 10.630M USD.
What Is Inotiv's Earnings Per Share (TTM)?
The Inotiv EPS (TTM) is -2.025.
When Is the Next Inotiv Earnings Date?
Inotiv will release its next earnings report on May 08, 2026.
From a Technical Analysis Perspective, Is NOTV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Inotiv Stock Split?
Inotiv has split 0 times.
How Many Employees Does Inotiv Have?
Inotiv has 1996 employees.
What is the current trading status of Inotiv (NOTV)?
As of May 08, 2026, Inotiv (NOTV) is trading at a price of 0.304 USD, with a previous close of 0.294 USD. The stock has fluctuated within a day range of 0.297 USD to 0.310 USD, while its 52-week range spans from 0.216 USD to 3.320 USD.
What Is Inotiv (NOTV) Price Target According to Analysts?
The average 12-month price target for Inotiv is 3.250 USD, with a high estimate of 5 USD and a low estimate of 1.5 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +969.08% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.